Your doctor may try different biologics before finding the one that works best for your psoriasis. You get these prescription drugs as injections or as intravenous (IV) infusions.You'll need to go ...

Findings published in JAMA Dermatology suggest that the use of immune checkpoint inhibitors may double psoriasis risk for ...

There are an estimated 430,000 to 560,000 patients with psoriasis in Japan, in which 11 biologics have been approved and are used in clinical practice for the treatment of moderate to severe disease.

Icotrokinra is a first-in-class targeted oral peptide that blocks interleukin (IL) 23 and its receptor, which plays a key ...

The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.

Posters presented at the American Academy of Dermatology Annual Meeting identified significant undertreatment of psoriasis and significant gaps in biologic medication treatment.

Biologics target specific parts of the immune system directly impacted by psoriasis, and they’re a big deal in both the medical community and to many with psoriasis. “Biologics are probably ...

Treatment switch rates for all biologics were 14.4% at 12 months and 26.0% at 24 months, with significant differences occurring among biologic classes in participants with psoriasis during 24 ...

Considering dual biologic therapy for psoriasis or eczema? Get a firsthand account of navigating insurance, potential side effects, and treatment outcomes.

A total of 7230 AEs were reported, including 680 SAEs (9.4%) with a fatal outcome in 0.6% of cases (n=40). There were 6137 AEs (84.9%) associated with biologic monotherapy and 1093 AEs (15.1% ...

The use of biologics to treat psoriasis does not affect antibody production after a patient has had a COVID infection or vaccination, according to a study. In early November 2023, the latest ...

The global chronic plaque psoriasis market is experiencing steady growth, propelled by increasing autoimmune disease prevalence and advancements in biologic therapies. Affecting 2-3% of the global ...